- Home
- ITRM vs IINN Comparison
ITRM vs IINN Comparison
Compare ITRM & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRM
- IINN
- Stock Information
- Founded
- ITRM 2015
- IINN 2018
- Country
- ITRM Ireland
- IINN Israel
- Employees
- ITRM N/A
- IINN N/A
- Industry
- ITRM Biotechnology: Pharmaceutical Preparations
- IINN Medical/Dental Instruments
- Sector
- ITRM Health Care
- IINN Health Care
- Exchange
- ITRM Nasdaq
- IINN Nasdaq
- Market Cap
- ITRM 40.0M
- IINN 32.4M
- IPO Year
- ITRM 2018
- IINN 2021
- Fundamental
- Price
- ITRM $0.48
- IINN $1.03
- Analyst Decision
- ITRM Strong Buy
- IINN Strong Buy
- Analyst Count
- ITRM 1
- IINN 1
- Target Price
- ITRM $9.00
- IINN $2.00
- AVG Volume (30 Days)
- ITRM 1.2M
- IINN 171.6K
- Earning Date
- ITRM 11-14-2025
- IINN 10-01-2025
- Dividend Yield
- ITRM N/A
- IINN N/A
- EPS Growth
- ITRM N/A
- IINN N/A
- EPS
- ITRM N/A
- IINN N/A
- Revenue
- ITRM $390,000.00
- IINN $289,000.00
- Revenue This Year
- ITRM N/A
- IINN N/A
- Revenue Next Year
- ITRM $482.25
- IINN $2,582.74
- P/E Ratio
- ITRM N/A
- IINN N/A
- Revenue Growth
- ITRM N/A
- IINN N/A
- 52 Week Low
- ITRM $0.36
- IINN $0.40
- 52 Week High
- ITRM $3.02
- IINN $1.65
- Technical
- Relative Strength Index (RSI)
- ITRM 41.91
- IINN 54.28
- Support Level
- ITRM $0.36
- IINN $0.90
- Resistance Level
- ITRM $0.49
- IINN $1.00
- Average True Range (ATR)
- ITRM 0.05
- IINN 0.06
- MACD
- ITRM -0.00
- IINN 0.02
- Stochastic Oscillator
- ITRM 43.47
- IINN 96.77
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.